233 related articles for article (PubMed ID: 23564449)
1. Heterogeneous nuclear ribonucleoprotein K (hnRNP-K) promotes tumor metastasis by induction of genes involved in extracellular matrix, cell movement, and angiogenesis.
Gao R; Yu Y; Inoue A; Widodo N; Kaul SC; Wadhwa R
J Biol Chem; 2013 May; 288(21):15046-56. PubMed ID: 23564449
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic Accumulation of Heterogeneous Nuclear Ribonucleoprotein K Strongly Promotes Tumor Invasion in Renal Cell Carcinoma Cells.
Otoshi T; Tanaka T; Morimoto K; Nakatani T
PLoS One; 2015; 10(12):e0145769. PubMed ID: 26713736
[TBL] [Abstract][Full Text] [Related]
3. Cellular nucleic acid binding protein suppresses tumor cell metastasis and induces tumor cell death by downregulating heterogeneous ribonucleoprotein K in fibrosarcoma cells.
Qiu J; Chen S; Su L; Liu J; Xiao N; Ou TM; Tan JH; Gu LQ; Huang ZS; Li D
Biochim Biophys Acta; 2014 Jul; 1840(7):2244-52. PubMed ID: 24594223
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase 12 is induced by heterogeneous nuclear ribonucleoprotein K and promotes migration and invasion in nasopharyngeal carcinoma.
Chung IC; Chen LC; Chung AK; Chao M; Huang HY; Hsueh C; Tsang NM; Chang KP; Liang Y; Li HP; Chang YS
BMC Cancer; 2014 May; 14():348. PubMed ID: 24885469
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA CASC11 interacts with hnRNP-K and activates the WNT/β-catenin pathway to promote growth and metastasis in colorectal cancer.
Zhang Z; Zhou C; Chang Y; Zhang Z; Hu Y; Zhang F; Lu Y; Zheng L; Zhang W; Li X; Li X
Cancer Lett; 2016 Jun; 376(1):62-73. PubMed ID: 27012187
[TBL] [Abstract][Full Text] [Related]
6. Regulation of angiogenesis and invasion by human Pituitary tumor transforming gene (PTTG) through increased expression and secretion of matrix metalloproteinase-2 (MMP-2).
Malik MT; Kakar SS
Mol Cancer; 2006 Nov; 5():61. PubMed ID: 17096843
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous nuclear ribonucleoprotein K upregulates the kinetochore complex component NUF2 and promotes the tumorigenicity of colon cancer cells.
Sugimasa H; Taniue K; Kurimoto A; Takeda Y; Kawasaki Y; Akiyama T
Biochem Biophys Res Commun; 2015 Mar; 459(1):29-35. PubMed ID: 25701787
[TBL] [Abstract][Full Text] [Related]
8. Growth factors regulate heterogeneous nuclear ribonucleoprotein K expression and function.
Mandal M; Vadlamudi R; Nguyen D; Wang RA; Costa L; Bagheri-Yarmand R; Mendelsohn J; Kumar R
J Biol Chem; 2001 Mar; 276(13):9699-704. PubMed ID: 11121407
[TBL] [Abstract][Full Text] [Related]
9. Interaction of hnRNP K with MAP 1B-LC1 promotes TGF-β1-mediated epithelial to mesenchymal transition in lung cancer cells.
Li L; Yan S; Zhang H; Zhang M; Huang G; Chen M
BMC Cancer; 2019 Sep; 19(1):894. PubMed ID: 31492158
[TBL] [Abstract][Full Text] [Related]
10. O-GlcNAc-induced nuclear translocation of hnRNP-K is associated with progression and metastasis of cholangiocarcinoma.
Phoomak C; Park D; Silsirivanit A; Sawanyawisuth K; Vaeteewoottacharn K; Detarya M; Wongkham C; Lebrilla CB; Wongkham S
Mol Oncol; 2019 Feb; 13(2):338-357. PubMed ID: 30444036
[TBL] [Abstract][Full Text] [Related]
11. Uncovering the Role of RNA-Binding Protein hnRNP K in B-Cell Lymphomas.
Gallardo M; Malaney P; Aitken MJL; Zhang X; Link TM; Shah V; Alybayev S; Wu MH; Pageon LR; Ma H; Jacamo R; Yu L; Xu-Monette ZY; Steinman H; Lee HJ; Sarbassov D; Rapado I; Barton MC; Martinez-Lopez J; Bueso-Ramos C; Young KH; Post SM
J Natl Cancer Inst; 2020 Jan; 112(1):95-106. PubMed ID: 31077320
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneous nuclear ribonucleoprotein K is a novel regulator of androgen receptor translation.
Mukhopadhyay NK; Kim J; Cinar B; Ramachandran A; Hager MH; Di Vizio D; Adam RM; Rubin MA; Raychaudhuri P; De Benedetti A; Freeman MR
Cancer Res; 2009 Mar; 69(6):2210-8. PubMed ID: 19258514
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53.
Zhou R; Shanas R; Nelson MA; Bhattacharyya A; Shi J
Int J Cancer; 2010 Jan; 126(2):395-404. PubMed ID: 19609950
[TBL] [Abstract][Full Text] [Related]
14. Role of heterogeneous nuclear ribonucleoprotein K in tumor development.
Chen Y; Zeng Y; Xiao Z; Chen S; Li Y; Zou J; Zeng X
J Cell Biochem; 2019 Sep; 120(9):14296-14305. PubMed ID: 31127648
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
Deryugina EI; Soroceanu L; Strongin AY
Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713
[TBL] [Abstract][Full Text] [Related]
16. N-myc downstream-regulated gene 1 promotes tumor inflammatory angiogenesis through JNK activation and autocrine loop of interleukin-1α by human gastric cancer cells.
Murakami Y; Watari K; Shibata T; Uba M; Ureshino H; Kawahara A; Abe H; Izumi H; Mukaida N; Kuwano M; Ono M
J Biol Chem; 2013 Aug; 288(35):25025-25037. PubMed ID: 23846687
[TBL] [Abstract][Full Text] [Related]
17. Loss-of-function screening by randomized intracellular antibodies: identification of hnRNP-K as a potential target for metastasis.
Inoue A; Sawata SY; Taira K; Wadhwa R
Proc Natl Acad Sci U S A; 2007 May; 104(21):8983-8. PubMed ID: 17483488
[TBL] [Abstract][Full Text] [Related]
18. Syntheses and evaluation of new Quinoline derivatives for inhibition of hnRNP K in regulating oncogene c-myc transcription.
Shu B; Zeng P; Kang S; Li PH; Hu D; Kuang G; Cao J; Li X; Zhang M; An LK; Huang ZS; Li D
Bioorg Chem; 2019 Apr; 85():1-17. PubMed ID: 30599408
[TBL] [Abstract][Full Text] [Related]
19. Withanone-rich combination of Ashwagandha withanolides restricts metastasis and angiogenesis through hnRNP-K.
Gao R; Shah N; Lee JS; Katiyar SP; Li L; Oh E; Sundar D; Yun CO; Wadhwa R; Kaul SC
Mol Cancer Ther; 2014 Dec; 13(12):2930-40. PubMed ID: 25236891
[TBL] [Abstract][Full Text] [Related]
20. Growth-arrest-specific 7C protein inhibits tumor metastasis via the N-WASP/FAK/F-actin and hnRNP U/β-TrCP/β-catenin pathways in lung cancer.
Tseng RC; Chang JW; Mao JS; Tsai CD; Wu PC; Lin CJ; Lu YL; Liao SY; Cheng HC; Hsu HS; Wang YC
Oncotarget; 2015 Dec; 6(42):44207-21. PubMed ID: 26506240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
